Version: 2024.08
Loading Scheme...
Normal steroids, i.e. cyclopenta(a)hydrophenanthrenes, containing carbon, hydrogen, halogen or oxygen [2013-01] |
C07J 1/00 | Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane [2013-01] |
C07J 1/0003 | . | {Androstane derivatives} [2013-01] |
C07J 1/0007 | . . | {not substituted in position 17} [2013-01] |
C07J 1/0011 | . . | {substituted in position 17 by a keto group} [2013-01] |
C07J 1/0014 | . . | {substituted in position 17 alfa, not substituted in position 17 beta} [2013-01] |
C07J 1/0018 | . . | {substituted in position 17 beta, not substituted in position 17 alfa} [2013-01] |
C07J 1/0022 | . . . | {the substituent being an OH group free esterified or etherified} [2013-01] |
C07J 1/0025 | . . . . | {Esters} [2013-01] |
C07J 1/0029 | . . . . | {Ethers} [2013-01] |
C07J 1/0033 | . . | {substituted in position 17 alfa and 17 beta} [2013-01] |
C07J 1/0037 | . . . | {the substituent in position 17 alfa being a saturated hydrocarbon group} [2013-01] |
C07J 1/004 | . . . | {the substituent in position 17 alfa being an unsaturated hydrocarbon group} [2013-01] |
C07J 1/0044 | . . . . | {Alkenyl derivatives} [2013-01] |
C07J 1/0048 | . . . . | {Alkynyl derivatives} [2013-01] |
C07J 1/0051 | . | {Estrane derivatives} [2013-01] |
C07J 1/0055 | . . | {not substituted in position 17} [2013-01] |
C07J 1/0059 | . . | {substituted in position 17 by a keto group} [2013-01] |
C07J 1/0062 | . . | {substituted in position 17 alfa not substituted in position 17 beta} [2013-01] |
C07J 1/0066 | . . | {substituted in position 17 beta not substituted in position 17 alfa} [2013-01] |
C07J 1/007 | . . . | {the substituent being an OH group free esterified or etherified} [2013-01] |
C07J 1/0074 | . . . . | {Esters} [2013-01] |
C07J 1/0077 | . . . . | {Ethers} [2013-01] |
C07J 1/0081 | . . | {Substituted in position 17 alfa and 17 beta} [2013-01] |
C07J 1/0085 | . . . | {the substituent in position 17 alfa being a saturated hydrocarbon group} [2013-01] |
C07J 1/0088 | . . . | {the substituent in position 17 alfa being an unsaturated hydrocarbon group} [2013-01] |
C07J 1/0092 | . . . . | {Alkenyl derivatives} [2013-01] |
C07J 1/0096 | . . . . | {Alkynyl derivatives} [2013-01] |
C07J 3/00 | Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom [2013-01] |
C07J 3/005 | . | {the carbon atom being part of a carboxylic function} [2013-01] |
C07J 5/00 | Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, {i.e. only one oxygen bound to position 21 by a single bond} [2013-01] |
C07J 5/0007 | . | {not substituted in position 17 alfa} [2013-01] |
C07J 5/0015 | . . | {not substituted in position 16} [2013-01] |
C07J 5/0023 | . . | {substituted in position 16} [2013-01] |
C07J 5/003 | . . . | {by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes} [2013-01] |
C07J 5/0038 | . . . . | {by an alkyl group} [2013-01] |
C07J 5/0046 | . | {substituted in position 17 alfa} [2013-01] |
C07J 5/0053 | . . | {not substituted in position 16} [2013-01] |
C07J 5/0061 | . . | {substituted in position 16} [2013-01] |
C07J 5/0069 | . . . | {by a saturated or unsaturated hydrocarbon group} [2013-01] |
C07J 5/0076 | . . . . | {by an alkyl group} [2013-01] |
C07J 5/0084 | . . . . | {by an alkylene group} [2013-01] |
C07J 5/0092 | . . . | {by an OH group free esterified or etherified} [2013-01] |
C07J 7/00 | Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms (C07J 5/00 takes precedence) [2013-01] |
C07J 7/0005 | . | {not substituted in position 21} [2013-01] |
C07J 7/001 | . . | {substituted in position 20 by a keto group} [2013-01] |
C07J 7/0015 | . . . | {not substituted in position 17 alfa} [2013-01] |
C07J 7/002 | . . . . | {not substituted in position 16} [2013-01] |
C07J 7/0025 | . . . . | {substituted in position 16} [2013-01] |
C07J 7/003 | . . . . . | {by a saturated or unsaturated hydrocarbon group} [2013-01] |
C07J 7/0035 | . . . . . | {by a hydroxy group free esterified or etherified} [2013-01] |
C07J 7/004 | . . . | {substituted in position 17 alfa} [2013-01] |
C07J 7/0045 | . . . . | {not substituted in position 16} [2013-01] |
C07J 7/005 | . . . . | {substituted in position 16} [2013-01] |
C07J 7/0055 | . . . . . | {by a saturated or unsaturated hydrocarbon group} [2013-01] |
C07J 7/006 | . . . . . | {by a hydroxy group free esterified or etherified} [2013-01] |
C07J 7/0065 | . . | {substituted in position 20 by an OH group free esterified or etherified} [2013-01] |
C07J 7/007 | . . . | {not substituted in position 17 alfa} [2013-01] |
C07J 7/0075 | . . . | {substituted in position 17 alfa} [2013-01] |
C07J 7/008 | . | {substituted in position 21} [2013-01] |
C07J 7/0085 | . . | {by an halogen atom} [2013-01] |
C07J 7/009 | . . | {by only one oxygen atom doubly bound} [2013-01] |
C07J 7/0095 | . . | {carbon in position 21 is part of carboxylic group} [2013-01] |
C07J 9/00 | Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane [2013-01] |
C07J 9/005 | . | {containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton} [2013-01] |
C07J 11/00 | Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3 [2013-01] |
C07J 13/00 | Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 {(for carbonyl groups C07J 1/00)} [2013-01] |
C07J 13/002 | . | {with double bond in position 13 (17)} [2013-01] |
C07J 13/005 | . | {with double bond in position 16 (17)} [2013-01] |
C07J 13/007 | . | {with double bond in position 17 (20)} [2013-01] |
C07J 15/00 | Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers [2013-01] |
C07J 15/005 | . | {Retrosteroids (9 beta 10 alfa)} [2013-01] |
C07J 17/00 | Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton (cardanolide, bufanolide C07J 19/00) [2013-01] |
C07J 17/005 | . | {Glycosides} [2013-01] |
C07J 19/00 | Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring [2013-01] |
C07J 19/005 | . | {Glycosides} [2013-01] |
C07J 21/00 | Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton [2013-01] |
C07J 21/001 | . | {Lactones} [2013-01] |
C07J 21/003 | . . | {at position 17} [2013-01] |
C07J 21/005 | . | {Ketals} [2013-01] |
C07J 21/006 | . . | {at position 3} [2013-01] |
C07J 21/008 | . . | {at position 17} [2013-01] |
Normal steroids, i.e. cyclopenta(a)hydrophenanthrenes, containing sulfur [2013-01] |
C07J 31/00 | Normal steroids containing one or more sulfur atoms not belonging to a hetero ring [2013-01] |
C07J 31/003 | . | {the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton} [2013-01] |
C07J 31/006 | . | {not covered by C07J 31/003} [2013-01] |
C07J 33/00 | Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton [2013-01] |
C07J 33/002 | . | {not condensed} [2013-01] |
C07J 33/005 | . | {spiro-condensed} [2013-01] |
C07J 33/007 | . . | {Cyclic thioketals} [2013-01] |
Normal steroids, i.e. cyclopenta(a)hydrophenanthrenes, containing nitrogen [2013-01] |
C07J 41/00 | Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring [2013-01] |
C07J 41/0005 | . | {the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton} [2013-01] |
C07J 41/0011 | . . | {Unsubstituted amino radicals} [2013-01] |
C07J 41/0016 | . . | {Oximes} [2013-01] |
C07J 41/0022 | . . | {Isocyanates; Isothiocyanates} [2013-01] |
C07J 41/0027 | . . | {Azides} [2013-01] |
| C07J 41/0033 | . | {not covered by C07J 41/0005} [2017-02] NOTE
|
C07J 41/0038 | . . | {with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group} [2013-01] |
C07J 41/0044 | . . | {with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group} [2013-01] |
C07J 41/005 | . . | {the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives} [2013-01] |
C07J 41/0055 | . . | {the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives} [2013-01] |
C07J 41/0061 | . . . | {one of the carbon atoms being part of an amide group} [2013-01] |
C07J 41/0066 | . . | {the 17-beta position being substituted by a carbon atom forming part of an amide group} [2013-01] |
C07J 41/0072 | . . | {the A ring of the steroid being aromatic} [2013-01] |
C07J 41/0077 | . . | {substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom} [2013-01] |
C07J 41/0083 | . . . | {substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings} [2013-01] |
C07J 41/0088 | . . | {containing unsubstituted amino radicals} [2013-01] |
C07J 41/0094 | . . | {containing nitrile radicals, including thiocyanide radicals} [2013-01] |
C07J 43/00 | Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton [2013-01] |
C07J 43/003 | . | {not condensed} [2013-01] |
C07J 43/006 | . | {spiro-condensed} [2013-01] |
C07J 51/00 | Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J 1/00 - C07J 43/00 [2016-05] |
C07J 53/00 | Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, {including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class} [2013-01] |
C07J 53/001 | . | {spiro-linked} [2013-01] |
C07J 53/002 | . | {Carbocyclic rings fused} [2013-01] |
C07J 53/004 | . . | {3 membered carbocyclic rings} [2013-01] |
C07J 53/005 | . . . | {in position 12} [2013-01] |
C07J 53/007 | . . . | {in position 6-7} [2013-01] |
C07J 53/008 | . . . | {in position 15/16} [2013-01] |
Nor- or homo steroids [2013-01] |
C07J 61/00 | Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms [2013-01] |
C07J 63/00 | Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms [2013-01] |
C07J 63/002 | . | {Expansion of ring A by one atom, e.g. A homo steroids} [2013-01] |
C07J 63/004 | . | {Expansion of ring B by one atom, e.g. B homo steroids} [2013-01] |
C07J 63/006 | . | {Expansion of ring C by one atom, e.g. C homo steroids} [2013-01] |
C07J 63/008 | . | {Expansion of ring D by one atom, e.g. D homo steroids} [2013-01] |
C07J 65/00 | Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of two rings, each by one atom [2013-01] |
C07J 67/00 | Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of two rings, each by one atom [2013-01] |
C07J 69/00 | Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one atom and expansion of only one ring by one atom [2013-01] |
C07J 71/00 | Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring (spiro-condensed heterocyclic rings C07J 21/00, C07J 33/00, C07J 43/00) [2013-01] |
C07J 71/0005 | . | {Oxygen-containing hetero ring} [2013-01] |
C07J 71/001 | . . | {Oxiranes} [2013-01] |
C07J 71/0015 | . . . | {at position 9(11)} [2013-01] |
C07J 71/0021 | . . . | {at position 14(15)} [2013-01] |
C07J 71/0026 | . . | {cyclic ketals} [2013-01] |
C07J 71/0031 | . . . | {at positions 16, 17} [2013-01] |
C07J 71/0036 | . | {Nitrogen-containing hetero ring} [2013-01] |
C07J 71/0042 | . . | {Nitrogen only} [2013-01] |
C07J 71/0047 | . . . | {at position 2(3)} [2013-01] |
C07J 71/0052 | . . . | {at position 16(17)} [2013-01] |
C07J 71/0057 | . . | {Nitrogen and oxygen} [2013-01] |
C07J 71/0063 | . . . | {at position 2(3)} [2013-01] |
C07J 71/0068 | . . . | {at position 16(17)} [2013-01] |
C07J 71/0073 | . | {Sulfur-containing hetero ring} [2013-01] |
C07J 71/0078 | . . | {containing only sulfur} [2013-01] |
C07J 71/0084 | . . . | {Episulfides} [2013-01] |
C07J 71/0089 | . . | {containing sulfur and oxygen} [2013-01] |
C07J 71/0094 | . . | {containing sulfur and nitrogen} [2013-01] |
C07J 73/00 | Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms [2013-01] |
C07J 73/001 | . | {by one hetero atom} [2013-01] |
C07J 73/003 | . . | {by oxygen as hetero atom} [2013-01] |
C07J 73/005 | . . | {by nitrogen as hetero atom} [2013-01] |
C07J 73/006 | . . | {by sulfur as hetero atom} [2013-01] |
C07J 73/008 | . | {by two hetero atoms} [2013-01] |
C07J 75/00 | Processes for the preparation of steroids in general [2013-01] |
C07J 75/005 | . | {Preparation of steroids by cyclization of non-steroid compounds} [2013-01] |